CodeSystem: ImmunizationRecommendationStatusCodes
Id: immunization-recommendation-status
Title: "Immunization Recommendation Status Codes"
Description: "The value set to instantiate this attribute should be drawn from a terminologically robust code system that consists of or contains concepts to support describing the status of the patient towards perceived immunity against a vaccine preventable disease. This value set is provided as a suggestive example."
* ^meta.lastUpdated = "2020-04-09T21:10:28.568+00:00"
* ^meta.profile = "http://hl7.org/fhir/StructureDefinition/shareablecodesystem"
* ^extension[0].url = "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg"
* ^extension[=].valueCode = #pher
* ^extension[+].url = "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm"
* ^extension[=].valueInteger = 1
* ^identifier.system = "urn:ietf:rfc:3986"
* ^identifier.value = "urn:oid:2.16.840.1.113883.4.642.1.1104"
* ^version = "1.0.0"
* ^status = #draft
* ^experimental = false
* ^date = "2024-03-09T14:36:19-07:00"
* ^publisher = "Health Level Seven International"
* ^contact.telecom[0].system = #url
* ^contact.telecom[=].value = "http://hl7.org"
* ^contact.telecom[+].system = #email
* ^contact.telecom[=].value = "hq@HL7.org"
* ^copyright = "This material derives from the HL7 Terminology (THO). THO is copyright Â©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license"
* ^caseSensitive = true
* ^valueSet = "http://terminology.hl7.org/ValueSet/immunization-recommendation-status"
* ^content = #complete
* #due "Due" "The patient is due for their next vaccination."
* #overdue "Overdue" "The patient is considered overdue for their next vaccination."
* #immune "Immune" "The patient is immune to the target disease and further immunization against the disease is not likely to provide benefit."
* #contraindicated "Contraindicated" "The patient is contraindicated for futher doses."
* #complete "Complete" "The patient is fully protected and no further doses are recommended."